Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Lange

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Nature Communications|September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Nature Communications|August 2, 2023
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationCelina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Kidney Medicine|April 9, 2026
Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI)Annemarie Albert, Louisa Blume, Salvatore Di Somma, et al.
Nature Biomedical Engineering|December 10, 2024
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinomaAristeidis Papargyriou, Mulham Najajreh, David P Cook, et al.
JCI Insight|July 3, 2020
Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncologyZahra Dantes, Hsi-Yu Yen, Nicole Pfarr, et al.
Nature|January 25, 2018
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Thomas Engleitner, Roman Maresch, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Nature Communications|September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Nature Communications|August 2, 2023
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationCelina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Kidney Medicine|April 9, 2026
Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI)Annemarie Albert, Louisa Blume, Salvatore Di Somma, et al.
Nature Biomedical Engineering|December 10, 2024
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinomaAristeidis Papargyriou, Mulham Najajreh, David P Cook, et al.
JCI Insight|July 3, 2020
Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncologyZahra Dantes, Hsi-Yu Yen, Nicole Pfarr, et al.
Nature|January 25, 2018
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Thomas Engleitner, Roman Maresch, et al.
Pageof 7